Loading
Latest filing published 15 Nov 2022 for Emerald Health Therapeutics, Inc..
No signal scores available.
Sukhwinder Singh Rai is a declared insider of Emerald Health Therapeutics, Inc., with filings sourced from SEDI. In total, 3 filings cover trades dated from 8 August 2016 to 10 November 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 15 November 2022: a transaction, in Emerald Health Therapeutics, Inc. Typically, a trade is published a median of 19 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations